This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...
Shares of Agios Pharmaceuticals AGIO tanked about 51% on Wednesday after it reported mixed top-line results from the phase III RISE UP study, which evaluated orally administered Pyrukynd (mitapivat) ...
Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ongoing trial of a regenerative cell therapy for Parkinson’s disease. The ...
Nov 19 (Reuters) - Agios Pharmaceuticals (AGIO.O), opens new tab said on Wednesday its sickle cell disease drug met one of its two main goals in a late-stage study of patients aged 16 and older but ...
In its mission to grow the reach of its pyruvate kinase (PK) activator Pyrukynd (mitapivat), Agios Pharmaceuticals has come up short of producing an unequivocal win in the key indication of sickle ...
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...
The S&P 500 Index ($SPX) (SPY) on Friday closed down -0.05%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.65%, and the Nasdaq 100 Index ($IUXX) (QQQ ...
ABSTRACT: Humanity often wastes a great deal of time on empty debates, while nature offers the best answers. Naturally, if we compare living conditions in icy waters or in the hellish heat of the ...
Shortly after John Currie was hired in 2019 as athletic director at Wake Forest, he had a Zoom call with Winston-Salem Mayor Pro Tem Denise Adams. Her ward northwest ...
This year, Big Pharma has been active on the M&A front in cell and gene therapy (CGT), with AbbVie setting down $2.1 billion for Capstan Therapeutics’ novel CAR T therapies, Eli Lilly dropping $1.3 ...
Intel's revival could ease US scrutiny on foreign rivals, say analysts Intel-Nvidia deal poses a longer-term threat to Asian chipmakers, they say TSMC shares finish down 1.6%, Samsung down 1% The ...
Abstract: Legalization is a crucial step in VLSI physical design, ensuring design rule compliance while minimizing disruptions to global placement. With the rise of multi-row-height cells in advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback